Science Explorer Back to mapMap
Discussion
Researcher · Symphogen (Denmark) · Denmark

Klaus Koefoed

Klaus Koefoed publishes mostly in Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Glycosylation and Glycoproteins Research.

ORCID 0000-0001-8945-3791 OpenAlex
World rank
#991,772
of 7,710,434 ranked researchers
Rank in Denmark
#7,418
of 43,819
Works
70
Citations
1.9k
Citations per work
27.2
h-index
15
i10-index 19Top 36% in Oncology
Klaus Koefoed

What does Klaus Koefoed research?

Klaus Koefoed's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (10%).

Health Sciences: 29 works · 40.9% of their workMedicine: 29 works · 40.9% of their workOncology: 15 works · 21.1% of their workRadiology, Nuclear Medicine and Imaging: 10 works · 14.5% of their workPulmonary and Respiratory Medicine: 4 works · 5.3% of their workLife Sciences: 22 works · 31.5% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 21.0% of their workMolecular Biology: 12 works · 17.1% of their workCancer Research: 3 works · 3.9% of their workImmunology and Microbiology: 7 works · 10.5% of their workImmunology: 7 works · 10.5% of their workEverything else: 19 works · 27.6% of their workTHEIR WORKKlaus Koefoed70works
Life Sciences32%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2940.9%
    1. Biochemistry, Genetics and Molecular Biology1521.0%
    2. Immunology and Microbiology710.5%
  3. Everything else1927.6%
  1. 1Oncology21% of their works
  2. 2Molecular Biology17% of their works
  3. 3Radiology, Nuclear Medicine and Imaging14% of their works
  4. 4Immunology10% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Klaus Koefoed's research?

The keywords of their largest research topics: Glycosylation, Chemotherapy, Fc Receptors, Therapeutic Antibodies, Breast Cancer, HER2, Targeted Therapy and Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Glycosylation162 topics
  2. Chemotherapy122 topics
  3. Fc Receptors111 topic
  4. Therapeutic Antibodies111 topic
  5. Breast Cancer71 topic
  6. HER271 topic
  7. Targeted Therapy62 topics
  8. Cancer51 topic
  9. Cetuximab51 topic
  10. Glycans51 topic
  11. KRAS Mutations51 topic
  12. ALK Inhibitors41 topic
  13. EGFR Mutations41 topic
  14. Foxp331 topic
  15. Hepatic Stellate Cells31 topic
  16. Liver Regeneration31 topic
  17. TGF-ß31 topic
  18. Cancer Genomics21 topic
  19. Mutational Signatures21 topic

Where does Klaus Koefoed work?

Klaus Koefoed's main affiliation in the publication record is Symphogen (Denmark), Denmark.

How many publications and citations does Klaus Koefoed have?

OpenAlex counts 70 works and 1,902 citations for Klaus Koefoed, an h-index of 15, ranking #991,772 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Klaus Koefoed. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.